Xilio Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | 11/13/2025 | 9.11 M | $7.67 M | 0.00% | 9.44% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 11/14/2025 | 4.57 M | $3.85 M | 0.00% | 4.74% |
| MERCK & CO., INC. | 11/12/2025 | 1.48 M | $1.25 M | 0.00% | 1.54% |
| TAKEDA PHARMACEUTICAL CO LTD | 11/13/2025 | 1.48 M | $1.24 M | 0.00% | 1.53% |
| VANGUARD GROUP INC | 11/07/2025 | 1.26 M | $1.06 M | 9.09% | 1.30% |
| MORGAN STANLEY | 11/14/2025 | 961.92 K | $810.61 K | -33.40% | 1.00% |
| AJU IB INVESTMENT CO., LTD. | 11/06/2025 | 667.74 K | $595.56 K | 0.00% | 0.69% |
| FMR LLC | 11/13/2025 | 511.82 K | $431.31 K | 0.00% | 0.53% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 328.97 K | $277.26 K | -11.01% | 0.34% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 328.79 K | $277.08 K | 39.64% | 0.34% |
| TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 11/14/2025 | 249.64 K | $210.44 K | 0.00% | 0.26% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 204.70 K | $172.50 K | 24.67% | 0.21% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 198.86 K | $167.58 K | 0.00% | 0.21% |
| STATE STREET CORP | 11/14/2025 | 163.89 K | $138.11 K | 277.71% | 0.17% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 87.79 K | $73.98 K | 12.51% | 0.09% |
| XTX TOPCO LTD | 11/14/2025 | 76.05 K | $64.08 K | 119.02% | 0.08% |
| NORTHERN TRUST CORP | 11/14/2025 | 66.61 K | $56.13 K | 0.00% | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 56.08 K | $47.26 K | 0.00% | 0.06% |
| TWO SIGMA SECURITIES, LLC | 11/14/2025 | 32.13 K | $27.08 K | 100.00% | 0.03% |
| LPL FINANCIAL LLC | 11/12/2025 | 31.00 K | $26.12 K | 0.00% | 0.03% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 29.69 K | $25.02 K | 100.00% | 0.03% |
| MARINER, LLC | 11/14/2025 | 25.00 K | $21.07 K | 0.00% | 0.03% |
| APTUS CAPITAL ADVISORS, LLC | 11/12/2025 | 25.00 K | $21.07 K | 0.00% | 0.03% |
| SEVENBRIDGE FINANCIAL GROUP, LLC | 11/13/2025 | 25.00 K | $19.33 K | 0.00% | 0.03% |
| HRT FINANCIAL LP | 11/14/2025 | 24.74 K | $20.00 K | 100.00% | 0.03% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 18.76 K | $15.81 K | 0.00% | 0.02% |
| UBS GROUP AG | 11/13/2025 | 13.65 K | $11.51 K | -94.31% | 0.01% |
| DUNHILL FINANCIAL, LLC | 11/12/2025 | 10.27 K | $8.66 K | 0.00% | 0.01% |
| INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV | 10/23/2025 | 10.00 K | $8.43 K | 0.00% | 0.01% |
| PINNACLE FINANCIAL GROUP, LLC / IL | 11/12/2025 | 10.00 K | $8.43 K | 0.00% | 0.01% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 11/14/2025 | 3.30 K | $2.78 K | 0.00% | 0.00% |
| BLACKROCK, INC. | 11/12/2025 | 2.04 K | $1.72 K | 0.00% | 0.00% |
| KEY FINANCIAL INC | 11/05/2025 | 830 | $691 | 0.00% | 0.00% |
| PRIVATE WEALTH MANAGEMENT GROUP, LLC | 10/17/2025 | 310 | $262 | 0.00% | 0.00% |
| CITIGROUP INC | 11/10/2025 | 258 | $217 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 246 | $207 | -25.68% | 0.00% |
| AVANTAX PLANNING PARTNERS, INC. | 10/31/2025 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| GHISALLO CAPITAL MANAGEMENT LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Xilio Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 43 institutional investors and hedge funds held shares of Xilio Therapeutics, Inc.. The most heavily invested institutionals were:
GILEAD SCIENCES, INC.: 9.11 M
Bain Capital Life Sciences Investors, LLC: 4.57 M
Merck & Co., Inc.: 1.48 M
TAKEDA PHARMACEUTICAL CO LTD: 1.48 M
VANGUARD GROUP INC: 1.26 M
MORGAN STANLEY: 961,917
22.86% of Xilio Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 23.60 M shares in the last 24 months. This purchase volume represents approximately $19.30 M in transactions.